NADIRAH ABDUL-MATEEN: Open Payments
NPI 1932806072 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$756 in 22 payments from 9 companies in 2025. Trend: 2023 $564 · 2024 $132 · 2025 $756
Food & beverage: $756
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 3 | $216 |
| AstraZeneca Pharmaceuticals LP | 4 | $192 |
| Novartis Pharmaceuticals Corporation | 5 | $102 |
| Alnylam Pharmaceuticals Inc. | 4 | $87 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $49 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $35 |
| Philips North America LLC | 1 | $33 |
| SCPHARMACEUTICALS INC. | 1 | $27 |
| Boston Scientific Corporation | 1 | $16 |
Products named: Barostim Neo System, WAINUA, LEQVIO, AMVUTTRA, LifeVest, Kerendia, Extended Holter, FUROSCIX.
Industry payments across GA — which companies pay providers there.
